Lv1
30 积分 2022-04-19 加入
Wild-type IDH1 maintains NSCLC stemness and chemoresistance through activation of the serine biosynthetic pathway
8小时前
已完结
Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy
1年前
已完结
SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma
2年前
已完结
CDK4/6 Inhibition Shows Clinical Activity in p16ink4A-Deficient Mesothelioma
2年前
已关闭
皖公网安备34019202002308
